Gene · 7114
TMSB4X: thymosin beta 4 X-linked
12 sourcesgene-search-2026-11-11-0.2.0
Cite this record
ConductScience Library. TMSB4X: thymosin beta 4 X-linked. Genes, record 7114. Release gene-search-2026-11-11-0.2.0, 11 Nov 2026. https://conductscience.org/library/genes/7114
On this page
Gene
Proteins1
Reviewed human proteins whose Swiss-Prot entry states the gene.
| UniProt entry | Protein | Length | Structures | Gene stated in |
|---|---|---|---|---|
| P62328 | Thymosin beta-4 | 44 | 3 | Ensembl, GeneID, HGNC |
Source UniProt
Patents122
Patents whose sequence listing contains this protein's exact sequence. A patent can list a sequence without claiming it.
| Publication | Published | SEQ ID NO | Protein | Source |
|---|---|---|---|---|
| JP 2026004568 A | 2026-01-14 | 67056 | P62328 | Espacenet |
| JP 2026004568 A | 2026-01-14 | 67057 | P62328 | Espacenet |
| JP 2026004568 A | 2026-01-14 | 67058 | P62328 | Espacenet |
| JP 2026004568 A | 2026-01-14 | 67059 | P62328 | Espacenet |
| EP 4650780 A2 | 2025-11-19 | 10344 | P62328 | Espacenet |
| EP 4641201 A2 | 2025-10-29 | 10664 | P62328 | Espacenet |
| JP 2025517969 A | 2025-06-12 | 10664 | P62328 | Espacenet |
| JP 2025517970 A | 2025-06-12 | 10344 | P62328 | Espacenet |
| WO 2024226499 A1 | 2024-10-31 | 26 | P62328 | Espacenet |
| EP 4373841 A1 | 2024-05-29 | 52 | P62328 | Espacenet |
1 to 10 of 122
See all 122 patentsDrugs0
Drugs a ChEMBL mechanism record says act on the gene's protein, through Open Targets.
None in this release.
Trials0
Trials of those drugs. A trial joins the gene only through a drug that acts on it.
None in this release.
NIH grants1,160
NIH grants whose papers are about the gene, through NIH's grant-paper links.
| Grant | Title | TMSB4X papers | Newest fiscal year |
|---|---|---|---|
| P30EY004068 | Core Grant for Vision Research | 10 | 2025 |
| R01GM073791 | Structural-Functional Basis of Actin Cytoskeleton Dynamics | 6 | 2025 |
| P30DA018310 | Neurometabolomics and Neuroproteomics Center on Cell-Cell Signaling | 5 | 2025 |
| R01EY013431 | Mechanisms of epithelial alterations in diabetic cornea | 5 | 2025 |
| R01HL076485 | Engineering Vascularized Cardiac Muscle | 4 | 2025 |
| P30CA006973 | Regional Oncology Research Center | 3 | 2025 |
| P30CA068485 | Cancer Center Support Grant | 3 | 2025 |
| P30EY007551 | Center Core Grant for Vision Research | 3 | 2025 |
| R01GM114666 | Molecular Mechanisms of Bacterial Toxins Targeting the Actin Cytoskeleton | 3 | 2025 |
| R35GM133485 | Mechanisms of coordinated actin and microtubule dynamics | 3 | 2025 |
1 to 10 of 1,160Source NIH's project files
See all 1,160 nih grantsPapers2,131
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Craniofacial Involvement Is Associated With Poor Prognosis in Extranodal Diffuse Large B-Cell Lymphoma. | Hematol Oncol | 2026 | 42781756 | PubTator, text mining | PubMed |
| Recombinant human Thymosin β4 ameliorates experimental colitis and intestinal fibrosis through suppression of mineralocorticoid receptor signaling. | Mol Biomed | 2026 | 42606759 | PubTator, text mining | PubMed |
| Peptide Supplements and Their Therapeutic Applications in Sports Medicine. | Am J Sports Med | 2026 | 42578445 | PubTator, text mining | PubMed |
| [TMSB4X Promotes Proliferation and Metastasis of T-cell Acute Lymphoblastic Leukemia Cells by Regulating the Wnt/β-catenin Signaling Pathway]. | Zhongguo Shi Yan Xue Ye Xue Za Zhi | 2026 | 42544648 | PubTator, text mining | PubMed |
| Urinary proteomic signature of exercise intolerance in patients at risk of heart failure: evidence from the HOMAGE trial. | EBioMedicine | 2026 | 42531722 | PubTator, text mining | PubMed |
| Spatial transcriptomic analysis reveals spatial features in human Stanford type A aortic dissection. | iScience | 2026 | 42519065 | PubTator, text mining | PubMed |
| Dysregulation of circulating damage-associated molecular patterns in diabetic foot syndrome. | Front Immunol | 2026 | 42440461 | PubTator, text mining | PubMed |
| PEGylated thymosin β4 is a thiol-site-specific prodrug treating myocardial infarction in vivo. | Bioeng Transl Med | 2026 | 42394899 | PubTator, text mining | PubMed |
| Sprayable bioadhesive microcarriers loaded with Tβ4-Engineered ADSC exosomes for diabetic wound healing. | Bioact Mater | 2026 | 42383202 | PubTator, text mining | PubMed |
| Longitudinal Trends of Salivary Oxidized Thymosin β4 and β10 in Preterm Infants with Bronchopulmonary Dysplasia. | Children (Basel) | 2026 | 42353940 | PubTator, text mining | PubMed |
1 to 10 of 2,131
See all 2,131 papersSources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this gene from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/genes/v1/7114
GET https://conductscience.org/api/genes/v1/7114/patents?page=2